Investor Area

Home / Investor Area / News / Presentation to international porphyria patient group
 

Presentation to international porphyria patient group

8 February 2016

 

Clinuvel Pharmaceuticals Ltd (ASX: CUV; XETRA‐DAX: UR9; ADR: CLVLY) presented to an international porphyria  patient meeting, held in Rotterdam, the Netherlands, on February 6, 2016. The presentation and speaking notes are  appended to this announcement.

 

Download PDF for more